FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2040876516> ?p ?o ?g. }

• W2040876516 endingPage "156" @default.
• W2040876516 startingPage "145" @default.
• W2040876516 abstract "Phase transitions in closed vesicles, i.e., microenvironments defined by the size of the vesicle, its contents, and permeability of its membrane are becoming increasingly important in several scientific disciplines including catalysis, growth of small crystals, cell function studies, and drug delivery. The membrane composed from lipid bilayer is in general impermeable to ions and larger hydrophilic ions. Ion transport can be regulated by ionophores while permeation of neutral and weakly hydrophobic molecules can be controlled by concentration gradients. Some weak acids or bases, however, can be transported through the membrane due to various gradients, such as electrical, ionic (pH) or specific salt (chemical potential) gradients. Upon permeation of appropriate species and reaction with the encapsulated species precipitation may occur in the vesicle interior. Alternatively, these molecules can also associate with the leaflets of the bilayer according to the transmembrane potential. Efficient liposomal therapeutics require high drug to lipid ratios and drug molecules should have, especially when associated with long circulating liposomes, low leakage rates. In this article we present very efficient encapsulation of two drugs via their intraliposomal precipitation, characterize the state of encapsulated drug within the liposome and try to fit the experimental data with a recently developed theoretical model. Nice agreement between a model which is based on chemical potential equilibration of membrane permeable species with experimental data was observed. The high loading efficiencies, however are only necessary but not sufficient condition for effective therapies. If adequate drug retention within liposomes, especially in the case of long-circulating ones, is not achieved, the therapeutic index decreases substantially. Anticancer drug doxorubicin precipitates in the liposome interior in a form of gel with low solubility product and practically does not leak out in blood circulation in the scale of days. With an antibiotic, ciprofloxacin, the high loading efficacy and test tube stability is not reproduced in in vitro plasma leakage assays and in vivo. We believe that the reasons are higher solubility product of precipitated drug in the liposome, larger fraction of neutral molecules due closer pK values of the drug with the pH conditions in the solutions and high membrane permeability of this molecule. High resolution cryoEM shows that encapsulated anticancer agent doxorubicin is precipitated in the form of bundles of parallel fibers while antibiotic ciprofloxacin shows globular precipitate. Doxorubicin gelatin also causes the change of vesicle shape." @default.
• W2040876516 created "2016-06-24" @default.
• W2040876516 creator A5010751448 @default.
• W2040876516 creator A5026776502 @default.
• W2040876516 creator A5042420536 @default.
• W2040876516 creator A5068725737 @default.
• W2040876516 creator A5070517779 @default.
• W2040876516 creator A5087375528 @default.
• W2040876516 date "1995-11-01" @default.
• W2040876516 modified "2023-10-18" @default.
• W2040876516 title "Transmembrane gradient driven phase transitions within vesicles: lessons for drug delivery" @default.
• W2040876516 cites W1969359430 @default.
• W2040876516 cites W2013342651 @default.
• W2040876516 cites W2021147222 @default.
• W2040876516 cites W2030879715 @default.
• W2040876516 cites W2036944284 @default.
• W2040876516 cites W2039350685 @default.
• W2040876516 cites W2039467756 @default.
• W2040876516 cites W2041508589 @default.
• W2040876516 cites W2055265722 @default.
• W2040876516 cites W2075397657 @default.
• W2040876516 cites W2078251025 @default.
• W2040876516 cites W2141415743 @default.
• W2040876516 cites W2158910367 @default.
• W2040876516 cites W2315027299 @default.
• W2040876516 cites W4213030902 @default.
• W2040876516 doi "https://doi.org/10.1016/0005-2736(95)00159-z" @default.
• W2040876516 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/7488619" @default.
• W2040876516 hasPublicationYear "1995" @default.
• W2040876516 type Work @default.
• W2040876516 sameAs 2040876516 @default.
• W2040876516 citedByCount "195" @default.
• W2040876516 countsByYear W20408765162012 @default.
• W2040876516 countsByYear W20408765162013 @default.
• W2040876516 countsByYear W20408765162014 @default.
• W2040876516 countsByYear W20408765162015 @default.
• W2040876516 countsByYear W20408765162016 @default.
• W2040876516 countsByYear W20408765162017 @default.
• W2040876516 countsByYear W20408765162018 @default.
• W2040876516 countsByYear W20408765162019 @default.
• W2040876516 countsByYear W20408765162020 @default.
• W2040876516 countsByYear W20408765162021 @default.
• W2040876516 countsByYear W20408765162022 @default.
• W2040876516 countsByYear W20408765162023 @default.
• W2040876516 crossrefType "journal-article" @default.
• W2040876516 hasAuthorship W2040876516A5010751448 @default.
• W2040876516 hasAuthorship W2040876516A5026776502 @default.
• W2040876516 hasAuthorship W2040876516A5042420536 @default.
• W2040876516 hasAuthorship W2040876516A5068725737 @default.
• W2040876516 hasAuthorship W2040876516A5070517779 @default.
• W2040876516 hasAuthorship W2040876516A5087375528 @default.
• W2040876516 hasBestOaLocation W20408765161 @default.
• W2040876516 hasConcept C12554922 @default.
• W2040876516 hasConcept C130316041 @default.
• W2040876516 hasConcept C159467904 @default.
• W2040876516 hasConcept C170493617 @default.
• W2040876516 hasConcept C178790620 @default.
• W2040876516 hasConcept C185154212 @default.
• W2040876516 hasConcept C185592680 @default.
• W2040876516 hasConcept C192157962 @default.
• W2040876516 hasConcept C24530287 @default.
• W2040876516 hasConcept C2779820397 @default.
• W2040876516 hasConcept C2992270614 @default.
• W2040876516 hasConcept C39944091 @default.
• W2040876516 hasConcept C41625074 @default.
• W2040876516 hasConcept C50670333 @default.
• W2040876516 hasConcept C55493867 @default.
• W2040876516 hasConcept C57947595 @default.
• W2040876516 hasConcept C86803240 @default.
• W2040876516 hasConceptScore W2040876516C12554922 @default.
• W2040876516 hasConceptScore W2040876516C130316041 @default.
• W2040876516 hasConceptScore W2040876516C159467904 @default.
• W2040876516 hasConceptScore W2040876516C170493617 @default.
• W2040876516 hasConceptScore W2040876516C178790620 @default.
• W2040876516 hasConceptScore W2040876516C185154212 @default.
• W2040876516 hasConceptScore W2040876516C185592680 @default.
• W2040876516 hasConceptScore W2040876516C192157962 @default.
• W2040876516 hasConceptScore W2040876516C24530287 @default.
• W2040876516 hasConceptScore W2040876516C2779820397 @default.
• W2040876516 hasConceptScore W2040876516C2992270614 @default.
• W2040876516 hasConceptScore W2040876516C39944091 @default.
• W2040876516 hasConceptScore W2040876516C41625074 @default.
• W2040876516 hasConceptScore W2040876516C50670333 @default.
• W2040876516 hasConceptScore W2040876516C55493867 @default.
• W2040876516 hasConceptScore W2040876516C57947595 @default.
• W2040876516 hasConceptScore W2040876516C86803240 @default.
• W2040876516 hasIssue "2" @default.
• W2040876516 hasLocation W20408765161 @default.
• W2040876516 hasLocation W20408765162 @default.
• W2040876516 hasOpenAccess W2040876516 @default.
• W2040876516 hasPrimaryLocation W20408765161 @default.
• W2040876516 hasRelatedWork W1600529641 @default.
• W2040876516 hasRelatedWork W1999630798 @default.
• W2040876516 hasRelatedWork W2052761397 @default.
• W2040876516 hasRelatedWork W2069274215 @default.
• W2040876516 hasRelatedWork W2087572532 @default.
• W2040876516 hasRelatedWork W2151889417 @default.
• W2040876516 hasRelatedWork W2351859943 @default.

• next